AGP Picks View all

Advertising Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Advertising Press Releases.

Press releases published on September 8, 2026

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)
Rani Therapeutics to Participate in Upcoming September Conferences
Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations
Upexi to Participate in FT Partners FinTech Conference 2026 on September 15th
Apollo to Present at the Barclays 24th Annual Global Financial Services Conference
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure
MIMEDX to Participate in Upcoming Investor Conferences
FTC Solar Begins Shipments on 330 MW Fraser Coast Project in Australia
Enphase Advances IQ Solid-State Transformer Development for AI Data Centers with Power Modules Now Being Built in Texas
Aduro Clean Technologies to Present Hydrochemolytic™ Technology for Polyolefin Recycling at Chemical Recycling Europe Annual Conference 2026
NowVertical Expands Google Cloud Practice into Brazil
Longevity Health Holdings Enters into Securities Purchase Agreement for Up to $625,000 in Gross Proceeds
International Land Alliance Adds Scalable AI Agentic Solution for Lead Generation
Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Liberty Global Agrees to Sell Dutch Towers Ahead of 2027 Ziggo Group Listing
Top pension funds grow at fastest rate since 2017
Windward Bio announces positive Phase 2 results of WIN378 in asthma demonstrating significant improvements in lung function and airway inflammation with twice-yearly dosing, and initiates Phase 3
DotKonnekt Expands Kompass Studio to Give Enterprises AI Sovereignty

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Advertising Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.